Myriad Genetics, Inc. – Strategy, SWOT and Corporate Finance Report
- Pages: 49
- Published: February 2017
- Report Code: 49B15276-7BD5-4A10-BC17-8EB62321F229
Myriad Genetics, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Myriad Genetics, Inc. (Myriad or 'the company') is a molecular diagnostic company. The company is engaged in the development and marketing of novel predictive medicine, personalized medicine and prognostic medicine products. The company operates in the US and Europe. It is headquartered in Salt Lake City, Utah.
Scope
– Detailed information on Myriad Genetics, Inc. required for business and competitor intelligence needs.
– A study of the major internal and external factors affecting Myriad Genetics, Inc. in the form of a SWOT analysis.
– An in-depth view of the busines
Reasons to buy
- Gain understanding of Myriad Genetics, Inc. and the factors that influence its strategies.- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Myriad Genetics, Inc. as a prospective partner, vendor or supplier.
-
Companies mentioned
Myriad Genetics, Inc.
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.